« Home

Home » Biosciences » Molecular Biology » Pecorino: Molecular Biology of Cancer 2e » Student resources » Hyperlinked bibliography » Chapter 10

Pecorino: Molecular Biology of Cancer 2e

Chapter 10

Further reading

Aggarwal, B.B. (2004) Nuclear factor-κB: the enemy within. Cancer Cells 6: 203-208. [DOI: 10.1016/j.ccr.2004.09.003]

Aggarwal, B.B., Shishodia, S., Sandur, S.K., Pandey, M.K., and Sethi, G. (2006) Inflammation and cancer: how hot is the link? Biochem. Pharmacol. 72: 1605-1621. [PubMed: 16889756] [DOI: 10.1016/j.bcp.2006.06.029]

Balkwill, F., Charles, K.A., and Mantovani, A. (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cells 7: 211-217. [DOI: 10.1016/j.ccr.2005.02.013]

Coussens, L.M. and Werb, Z. (2002) Inflammation and cancer. Nature 420: 860-867. [PubMed: 12490959] [DOI: 10.1038/nature01322]

Escarcega, R.O., Fuentes-Alexandro, S., Garcia-Carrasco, M., Gatica, A., and Zamora, A. (2007) The transcription factor Nuclear Factor-kappa B and cancer. Clin. Oncol. 19: 154-161. [DOI: 10.1016/j.clon.2006.11.013]

Farazi, P.A. and DePinho, R.A. (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Rev. Cancer 6: 674-687. [DOI: 10.1038/nrc1934]

Hatakeyama, M. (2004) Oncogenic mechanisms of the Helicobacter pylori Caga protein. Nature Rev. Cancer 4: 688-694. [DOI: 10.1038/nrc1433]

Huang, K.-Y. and Lin, S.-R. (2000) Nationwide vaccination: a success story in Taiwan. Vaccine 18: S35-S38. [PubMed: 10683542] [DOI: 10.1016/S0264-410X(99)00460-0]

Karin, M. (2006) Nuclear factor-κB in cancer development and progression. Nature 441: 431-436. [PubMed: 16724054] [DOI: 10.1038/nature04870]

Karin, M., Yamamoto, Y., and Wang, Q.M. (2004) The IKK NF-κB system: a treasure trove for drug development. Nature Rev. Drug Discov. 3: 17-26. [DOI: 10.1038/nrd1279]

Kelley, J.R. and Duggan, J.M. (2003) Gastric cancer epidemiology and risk factors. J. Clin. Epidemiol. 56: 1-9. [PubMed: 12589864] [DOI: 10.1016/S0895-4356(02)00534-6]

Li, Q., Withoff, S., and Verma, I.M. (2005) Inflammation-associated cancer: NF-κB is the lynchpin. Trends Immunol. 26: 318-325. [PubMed: 15922948] [DOI: 10.1016/j.it.2005.04.003]

Lowy, D.R. and Schiller, J.T. (2006) Prophylactic human papillomavirus vaccines. J. Clin. Invest. 116: 1167-1173. [PubMed: 16670757] [DOI: 10.1172/JCI28607]

Matysiak-Budnik, T. and Megraud, F. (2006) Helicobacter pylori infection and gastric cancer. Eur. J. Cancer 42: 708-716. [PubMed: 16556496] [DOI: 10.1016/j.ejca.2006.01.020]

Munoz, N., Bosch, F.X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K.V., Snijders, P.J.F., and Meijer, C.J.L.M. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J. Med. 348: 518-527. [DOI: 10.1056/NEJMoa021641]

Pagano, J.S., Blaser, M., Buendia, M.-A., Damania, B., Khalili, K., Raab-Traub, N., and Roizman, B. (2004) Infectious agents and cancer: criteria for a causal relation. Semin. Cancer Biol. 14: 453-471. [PubMed: 15489139] [DOI: 10.1016/j.semcancer.2004.06.009]

Radkov, S.A., Kellam, P., and Boshoff, C. (2000) The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nature Med. 6: 1121-1127. [PubMed: 11017143] [DOI: 10.1038/80459]

Tan, T.-T. and Coussens, L.M. (2007) Humoral immunity, inflammation and cancer. Curr. Opin. Immunol. 19: 209-216. [PubMed: 17276050] [DOI: 10.1016/j.coi.2007.01.001]

Vogelmann, R. and Amieva, M.R. (2007) The role of bacterial pathogens in cancer. Curr. Opin. Microbiol. 10: 76-81. [PubMed: 17208515] [DOI: 10.1016/j.mib.2006.12.004]

Zhang, X., Zhang, H., and Ye, L. (2006) Effects of hepatitis B virus X protein on the development of liver cancer. J. Lab. Clin. Med. 147: 58-66. [PubMed: 16459163] [DOI: 10.1016/j.lab.2005.10.003]

zur Hausen, H. (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nature Rev. Cancer 2: 342-350. [DOI: 10.1038/nrc798]

Selected Special Topics

Cox, T. and Cuzick, J. (2006) HPV DNA testing in cervical cancer screening: from evidence to policies. Gynecol. Oncol. 103: 8-11. [PubMed: 16919716] [DOI: 10.1016/j.ygyno.2006.07.030]

Greten, F.R., Eckmann, L., Greten, T.F., Park, J.M., Egan, L.J., Kagnoff, M.F., and Karin, M. (2004) IKKb links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118: 285-296. [PubMed: 15294155] [DOI: 10.1016/j.cell.2004.07.013]

Harper, D., Franco, E., Wheeler, C., Ferris, D., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., and De Carvalho, N. (2004) Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women, a randomized controlled trial. Lancet 364: 1757-1765.

Houghton, J., Stoicov, C., Nomura, S., Rogers, A.B., Carlson, J., Li, H., Cai, X., Fox, J.G., Goldenring, J.R., and Wang, T.C. (2004) Gastric cancer originating from bone marrow-derived cells. Science 306: 1568-1571. [PubMed: 15567866] [DOI: 10.1126/science.1099513]

Kismet, K, Akay, M.T., Abbasoglu, O., and Ercan, A. (2004) Celocoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect. Prev. 28: 127-142. [PubMed: 15068837] [DOI: 10.1016/j.cdp.2003.12.005]

Naugler, W.E., Sakurai, T., Kim, S., Maeda, S., Kim, K.H., Elsharkawy, A.M., and Karin, M. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317: 121-124. [PubMed: 17615358] [DOI: 10.1126/science.1140485]

Pikarsky, E., Porat, R.M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., and Ben-Neriah, Y. (2004) NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466. [PubMed: 15329734] [DOI: 10.1038/nature02924]

Steinbach, G., Lynch, P.M., Phillips, R.K.S., Wallace, M.H., Hawk, E., Gordon, G.B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., Su, L.-K., Levin, B., Godio, L., Patterson, S., Rodriguez-Bigas, M.A., Jester, S.L., King, K.L., Schumacher, M., Abbruzzese, J., DuBois, R.N., Hittelman, W.N., Zimmerman, S., Sherman, J.W., and Kelloff, G. (2000) The effect of Celecoxib, a cyclooxygenease-2 inhibitor, in familial adenomatous polyposis. N Engl J. Med. 342: 1946-1952. [DOI: 10.1056/NEJM200006293422603]

Villa, L.L., Costa, R.L., Petta, C.A., Andrade, R.P., Ault, K.A., Giuliano, A.R., Wheeler, C.M., Koutsky, L.A., Malm, C., Lehtinen, M., Skjeldestad, F.E., Olsson, S.E., Steinwall, M., Brown, D.R., Kurman, R.J., Ronnett, B.M., Stoler, M.H., Ferenczy, A., Harper, D.M., Tamms, G.M., Yu, J., Lupinacci, L., Railkar, R., Taddeo, F.J., Jansen, K.U., Esser, M.T., Sings, H.L., Saah, A.J., and Barr, E. (2005) Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6: 271-278. [PubMed: 15863374] [DOI: 10.1016/S1470-2045(05)70101-7]

Wong, B.C.-Y., Lam, S.K., Wong, W.M., Chen, J.S., Zheng, T.T., Feng, R.E., Lai, K.C., Hu, W.H.C., Yuen, S.T., Fong, D.Y.K., Ho, J., Ching, C.K., and Chen, J.S. (2004) Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. J. Am. Med. Assoc. 291: 187-194. [DOI: 10.1001/jama.291.2.187]